Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Gastroenterology|March 8, 2014
Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trialXavier Forns, Eric Lawitz, Stefan Zeuzem, et al.
Clinics and Research in Hepatology and Gastroenterology|February 1, 2015
Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC studyFrançois Bailly, Victor Virlogeux, Cécilie Dufour, et al.
Journal of Hepatology|July 20, 2014
Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis CJean-Pierre Bronowicki, Vlad Ratziu, Adrian Gadano, et al.
World Journal of Gastroenterology|May 4, 2017
Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohortXavier Adhoute, Guillaume Pénaranda, Jean Luc Raoul, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
18F-FDG and 18F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter StudyAlexandre Cochet, Victor Besson, Aurélie Bertaut, et al.
Journal of Hepatology|April 24, 2012
Methyl donor deficiency impairs fatty acid oxidation through PGC-1α hypomethylation and decreased ER-α, ERR-α, and HNF-4α in the rat liverShabnam Pooya, Sébastien Blaise, Maira Moreno Garcia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2015
High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH StudyLionel Piroth, Hubert Paniez, Anne Marie Taburet, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis BPatrick Marcellin, Herve Mommeja-Marin, Stephen L Sacks, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 25, 2024
Multiparametric renal function assessment in cirrhotic patients shows high prevalence of medically actionable changes in multiple modulesRichard Belmonte, Maël Silva-Rodriguez, Françoise Barbé, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 20, 2006
Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trailRichard Moreau, Dominique-Charles Valla, Isabelle Durand-Zaleski, et al.
Pageof 20